ArticleJournal of neuro-oncology2026

Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases.

Fabien Boux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.